본문 바로가기

Discovery of a novel alpha isoform of the long-known enzyme LDHA provides new insights into cancer research

문서 유형
연구출판물 · 기타
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
FEBS JOURNAL292(9) · pp.2219 · 2025
피인용
Web of Science 3Scopus 2
FWCI (Scopus)
1.44
JCR IF
JCR 2024 4.2
ISSN
1742-464X

저자

  1. 박원영제1저자Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, Gyeongsangnam D, South Korea
  2. Wei, ShiboGwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea
  3. Ryu, DongryeolGwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea
  4. 하기태교신저자Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, Gyeongsangnam D, South Korea

초록

Lactate dehydrogenase A is a key enzyme in energy metabolism, with significant roles in cancer progression. Huang et al. identified LDHAα, a novel LDHA isoform derived from an alternative transcript initiated at AUG198, producing a protein 3 kDa larger than canonical LDHA. LDHAα exhibits enhanced glycolytic activity and promotes glucose uptake, lactate production, and tumor growth more effectively than LDHA. Regulated by c-MYC and FOXM1, LDHAα is mainly cytoplasmic and serves as a potential cancer biomarker and therapeutic target. These findings highlight LDHAα's unique role in cancer metabolism and its potential for advancing targeted cancer therapies.

키워드

c-MYCFOXM1glycolysisLDHALDHAα

식별자

Scopus EID
2-s2.0-86000302902
WoS UID
001438605600001